Minirin (Desmopressin Acetate)

Desmopressin Acetate, the active ingredient in Minirin, is a vasopressin (antidiuretic hormone) analog presented as a nasal spray for intranasal administration. It selectively reduces excessive urine production in patients with central diabetes insipidus and helps control nocturnal enuresis in children and adolescents.

GNH USA supplies Minirin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable sourcing for regulated markets and ensuring all batches meet EU pharmacopoeial specifications, ensuring product integrity.

Desmopressin acetate is used to manage conditions related to antidiuretic hormone deficiency or excess urine production. - Central diabetes insipidus: reduces polyuria and stabilizes fluid balance. - Nocturnal enuresis: decreases nighttime urine output, improving bladder control in children. - Von Willebrand disease (type 1) and mild hemophilia A: promotes release of factor VIII and von Willebrand factor to improve hemostasis.

Desmopressin nasal spray may cause a range of adverse reactions.

Common Side Effects: - Nasal irritation or congestion. - Headache. - Mild hyponatremia. - Nausea. - Thirst.

Serious or Rare Side Effects: - Severe hyponatremia leading to seizures. - Water intoxication with cerebral edema. - Allergic reactions, including anaphylaxis. - Nasal septum perforation (rare).

Before prescribing Minirin, clinicians should consider several safety measures. - Assess serum sodium before initiating therapy: monitor for hyponatremia. - Avoid use in patients with uncontrolled hypertension: risk of fluid overload. - Limit fluid intake during treatment: prevent water intoxication. - Use with caution in elderly patients: increased sensitivity to antidiuretic effects. - Store at ambient temperature: keep in original container, protect from moisture and light.

Desmopressin may interact with other medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Concomitant use with thiazide diuretics: may exacerbate hyponatremia. - Combination with other ADH analogues: risk of excessive water retention.

Moderate Interactions (Monitor Closely): - NSAIDs: can potentiate antidiuretic effect. - SSRIs and other serotonergic agents: may increase risk of hyponatremia. - Alcohol: may enhance water retention and hyponatremia risk.